Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ACETYLCYSTEINE Cause Benign prostatic hyperplasia? 118 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Benign prostatic hyperplasia have been filed in association with ACETYLCYSTEINE (Acetylcysteine). This represents 4.9% of all adverse event reports for ACETYLCYSTEINE.

118
Reports of Benign prostatic hyperplasia with ACETYLCYSTEINE
4.9%
of all ACETYLCYSTEINE reports
1
Deaths
113
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From ACETYLCYSTEINE?

Of the 118 reports, 1 (0.8%) resulted in death, 113 (95.8%) required hospitalization, and 7 (5.9%) were considered life-threatening.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ACETYLCYSTEINE. However, 118 reports have been filed with the FAERS database.

What Other Side Effects Does ACETYLCYSTEINE Cause?

Drug ineffective (428) Dyspnoea (297) Off label use (250) Acute kidney injury (224) Hypertension (216) Asthma (197) Chronic obstructive pulmonary disease (187) Productive cough (164) Wheezing (161) Toxicity to various agents (158)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which ACETYLCYSTEINE Alternatives Have Lower Benign prostatic hyperplasia Risk?

ACETYLCYSTEINE vs ACETYLLEUCINE ACETYLCYSTEINE vs ACETYLLEUCINE, L- ACETYLCYSTEINE vs ACETYLSALICYLIC ACID ACETYLCYSTEINE vs ACITRETIN ACETYLCYSTEINE vs ACLARUBICIN

Related Pages

ACETYLCYSTEINE Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia ACETYLCYSTEINE Demographics